Get the Stockscreener App
3.63
7.72%
0.26
After Hours:
3.50
-0.13
-3.58%
Rezolute Inc stock is traded at $3.63, with a volume of 3.69M.
It is up +7.72% in the last 24 hours and up +44.62% over the past month.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
See More
Previous Close:
$3.37
Open:
$3.36
24h Volume:
3.69M
Relative Volume:
0.56
Market Cap:
$336.60M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-2.8583
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
+24.32%
1M Performance:
+44.62%
6M Performance:
-41.45%
1Y Performance:
-25.31%
1-Day Range:
$3.2703
$3.745
1-Week Range:
$2.94
$3.745
52-Week Range:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
3.63 | 312.49M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-11-25 | Downgrade | Craig Hallum | Buy → Hold |
| Dec-11-25 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Rezolute (NASDAQ:RZLT) Announces Quarterly Earnings Results - MarketBeat
Rezolute (RZLT) Reports Decline in Cash Reserves by Year-End - GuruFocus
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - The Manila Times
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire Inc.
Can Rezolute Inc. stock hit record highs againWeekly Trend Recap & Weekly High Potential Stock Alerts - mfd.ru
Faruqi & Faruqi Investigates Losses in Rezolute Stock - Intellectia AI
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire
Surprises Report: Is Rezolute Inc stock trending bullishJuly 2025 Recap & Community Verified Swing Trade Signals - baoquankhu1.vn
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Rezolute, Inc. to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative
Rezolute (RZLT) Projected to Post Earnings on Wednesday - MarketBeat
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investig - The National Law Review
Profit Recap: Should I hold or sell Lumen Technologies Inc nowForecast Cut & Proven Capital Preservation Methods - baoquankhu1.vn
Rezolute’s Phase 3 SunRIZE study for Ersodetug fails to meet primary and secondary endpoints despite analyst backing - MSN
Rezolute, Inc. (NASDAQ:RZLT) Sees Significant Increase in Short Interest - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Rezolute (NASDAQ:RZLT) Shares Down 3.8%What's Next? - MarketBeat
Faruqi & Faruqi Encourages Rezolute Investors to Discuss Legal Options - intellectia.ai
Analysis Recap: Will Rezolute Inc benefit from rate cutsJuly 2025 Volume & Low Volatility Stock Recommendations - baoquankhu1.vn
Rezolute shares in focus after RA Capital discloses 9.9% stake - MSN
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Prime Publishers, Inc.
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc.RZLT - PR Newswire
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - GlobeNewswire Inc.
Trading Recap: Is Rezolute Inc a top pick in the sectorPortfolio Gains Summary & Safe Swing Trade Setups - baoquankhu1.vn
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The Malaysian Reserve
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
FMR LLC Significantly Reduces Holdings in Rezolute Inc. - GuruFocus
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Fail - GuruFocus
Entry Recap: Is Rezolute Inc a top pick in the sectorMarket Activity Summary & Precise Swing Trade Alerts - baoquankhu1.vn
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - GlobeNewswire
RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. for Possible Securities Fraud Violations - marketscreener.com
RZLT Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com
When the placebo isn’t inert: Rezolute’s CEO on the 40% response rate that upended a phase 3 trial - drugdiscoverytrends.com
Rezolute Downgrade Brings Investor Caution Amid Study Challenges - StocksToTrade
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):